Alapis, that's not what I'm telling you. Gerald stated the LymPro revenue guidance would be announced in the Q2 conference call. He stated nothing about the revenue guidance being in the 10-Q. You asked what I expected from the 10-Q and I reported what I expect, based on previous 10-Qs and what Gerald has told us.

In the past, conference calls have been done on the same day or several days after the filing. We won't know when this one will be done until the PR is issued. If the call is done on the same day as the filing, the guidance may be included in the 10-Q. If the call is done on a day after the filing, the guidance may be reported in an 8-K filing.

No one should make any assumptions about the guidance or state of the company based on when the guidance is released.